CoreNest combines a $25M VC Fund with a corporate-driven accelerator to identify, validate, and scale high-potential startups across Latin America.
For informational purposes only. Nothing on this website constitutes investment, legal, or tax advice, or an offer to sell or solicit securities. All investments involve risk, including potential loss of principal.
Any projections, return simulations, or market estimates shown are hypothetical, illustrative only, and are not guarantees of future performance. Past performance does not guarantee future results.
A $25M institutional vehicle deploying into seed and pre-seed LATAM startups under an American waterfall structure.
Minimum ticket $500K. Model how your commitment translates into MOIC, IRR, DPI and TVPI — by portfolio mix or by walking through a single illustrative deal under American waterfall.
The MOIC multiplies a base. Pick which one to use for the simulation — both are valid but give different results due to fee drag.
Your ownership (2.00%) is always respected on the proceeds the fund generates.
For informational purposes only. Nothing on this website constitutes investment, legal, or tax advice, or an offer to sell or solicit securities. All investments involve risk, including potential loss of principal.
Any projections, return simulations, or market estimates shown are hypothetical, illustrative only, and are not guarantees of future performance. Past performance does not guarantee future results.
Reference: a single 100x outcome (e.g. $125K → $12.76M, see Single Deal mode) can carry the entire fund.
For informational purposes only. Nothing on this website constitutes investment, legal, or tax advice, or an offer to sell or solicit securities. All investments involve risk, including potential loss of principal.
Any projections, return simulations, or market estimates shown are hypothetical, illustrative only, and are not guarantees of future performance. Past performance does not guarantee future results.
Capital is called quarterly as the fund deploys. Your first call covers prepaid management fees for Years 1–2 plus your share of the first tranche of investments.
| Quarter | Purpose | Amount (LP) | Cumulative Called | Remaining |
|---|---|---|---|---|
| Q2 2026 | First close · prepaid fees Y1–Y2 + first tranche + expenses | $143K | $143K | $357K |
| Q3 2026 | Deployment tranche · follow-ons & new investments | $35K | $178K | $322K |
| Q4 2026 | Deployment tranche · follow-ons & new investments | $35K | $212K | $288K |
| Q1 2027 | Deployment tranche · follow-ons & new investments | $35K | $247K | $253K |
| Q2 2027 | Deployment tranche · follow-ons & new investments | $35K | $282K | $219K |
| Q3 2027 | Deployment tranche · follow-ons & new investments | $35K | $316K | $184K |
| Q4 2027 | Deployment tranche · follow-ons & new investments | $35K | $351K | $149K |
| Q1 2028 | Deployment tranche · follow-ons & new investments | $35K | $385K | $115K |
| Q2 2028 | Deployment tranche · follow-ons & new investments | $35K | $420K | $80K |
| Q3 2028 | Annual management fee | $10K | $430K | $70K |
| Q2 2029 | Annual management fee | $10K | $440K | $60K |
| Q2 2030 | Annual management fee | $10K | $450K | $50K |
| Q2 2031 | Annual management fee | $10K | $460K | $40K |
| Q2 2032 | Annual management fee | $10K | $470K | $30K |
| Q2 2033 | Annual management fee | $10K | $480K | $20K |
| Q2 2034 | Annual management fee | $10K | $490K | $10K |
| Q2 2035 | Annual management fee | $10K | $500K | $0K |
CoreNest operates under a formal MOU with the Government of El Salvador and a network of regional and global partners.
From the highest homicide rate in the world to one of the safest countries in the Americas — in 4 years.
Bitcoin legal tender, AI-friendly regulation, public-private alignment around emerging technology.
USD economy, US time zone, dollarized exits — a clean operational base for regional expansion.
Direct relationships with the Presidency, BCR, CONAMYPE and Bitcoin Office.
Tax incentives, residency programs, and operational support for relocating founders and corporates.